Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Voyager Therapeutics, Inc. (NASDAQ:VYGR) represented a move of -11.97 percent or $-1.11 per share and closed its previous day trading session at $12.31. 1.32 Million Shares were traded in the last trading session with an Average Volume of 290.37 Million Shares. The stock currently has a Market Capitalization of 392.73 Million.
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson’s disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington’s disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
The stock traded between $11.00 and $31.91 over 1-Year time period showing its price to sales ratio of 35.7. Voyager Therapeutics, Inc. (NASDAQ:VYGR) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-27.96 and 200-Day Simple Moving Average of $-37.3. Its Price to Free Cash Flow is 0 and Price to Book of 4.81.
Analyst’s recommended the stock as 1.8 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Voyager Therapeutics, Inc. (NASDAQ:VYGR) reported its Actual EPS of $-0.63/share. The analysts offering Earnings Estimates for the company were believing that Voyager Therapeutics, Inc. could bring EPS of $-0.79/share. The difference between Actual EPS and Estimated EPS was 0.16 Percent. Thus showing an Earnings Surprise of 20.3 Percent.
ANSYS, Inc. (NASDAQ:ANSS)
In the last trading session, ANSYS, Inc. (NASDAQ:ANSS) added its value by 6.18% closing at the price of $169.68. The stock currently has market capitalization of 14.27 Billion, with average volume of 561.25 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently ANSYS, Inc. (NASDAQ:ANSS) is showing beta of 1.31. This particular value of beta suggests that ANSYS, Inc. (NASDAQ:ANSS) has historically moved 131% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for ANSYS, Inc. (NASDAQ:ANSS) is at $3.71.
The stock currently has RSI of 61.81. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
ANSYS, Inc., develops and globally markets engineering simulation software and technologies widely used by engineers and designers across a broad spectrum of industries. The Company focuses on the development of open and flexible solutions that enable users to analyze designs directly on the desktop, providing a common platform for fast, efficient and cost- conscious product development, from design concept to final-stage testing and validation. The Company and its global network of channel partners provide sales, support and training for customers.
ANSYS, Inc. (NASDAQ:ANSS) topped its 52-week high price of $190.45 on 09/14/18 and 52-Week Low Price of $140.78 on 10/26/18. The Stock currently has P/E (price to earnings ttm) of 45.7 and Weekly volatility of 3.27% and monthly volatility of 3.18% respectively.